380 related articles for article (PubMed ID: 22199999)
1. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.
Laurent S; Mahmoudi M
Int J Mol Epidemiol Genet; 2011; 2(4):367-90. PubMed ID: 22199999
[TBL] [Abstract][Full Text] [Related]
2. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
Mahmoudi M; Sant S; Wang B; Laurent S; Sen T
Adv Drug Deliv Rev; 2011; 63(1-2):24-46. PubMed ID: 20685224
[TBL] [Abstract][Full Text] [Related]
3. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
4. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy.
Zhi D; Yang T; Yang J; Fu S; Zhang S
Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124
[TBL] [Abstract][Full Text] [Related]
5. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
Kievit FM; Zhang M
Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
[TBL] [Abstract][Full Text] [Related]
6. Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging.
Sharifi S; Seyednejad H; Laurent S; Atyabi F; Saei AA; Mahmoudi M
Contrast Media Mol Imaging; 2015; 10(5):329-55. PubMed ID: 25882768
[TBL] [Abstract][Full Text] [Related]
7. Superparamagnetic Iron Oxide Nanoparticles Modified with Silica Layers as Potential Agents for Lung Cancer Treatment.
Reczyńska K; Marszałek M; Zarzycki A; Reczyński W; Kornaus K; Pamuła E; Chrzanowski W
Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32486431
[TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic iron oxide nanoparticles (SPIONs) as a multifunctional tool in various cancer therapies.
Musielak M; Piotrowski I; Suchorska WM
Rep Pract Oncol Radiother; 2019; 24(4):307-314. PubMed ID: 31193459
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics.
Santhosh PB; Ulrih NP
Cancer Lett; 2013 Aug; 336(1):8-17. PubMed ID: 23664890
[TBL] [Abstract][Full Text] [Related]
11. Superparamagnetic Iron Oxide Nanoparticles-Current and Prospective Medical Applications.
Dulińska-Litewka J; Łazarczyk A; Hałubiec P; Szafrański O; Karnas K; Karewicz A
Materials (Basel); 2019 Feb; 12(4):. PubMed ID: 30791358
[TBL] [Abstract][Full Text] [Related]
12. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
Wahajuddin ; Arora S
Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
[TBL] [Abstract][Full Text] [Related]
13. Recent Progress in Iron Oxide Nanoparticles as Therapeutic Magnetic Agents for Cancer Treatment and Tissue Engineering.
Nabavinia M; Beltran-Huarac J
ACS Appl Bio Mater; 2020 Dec; 3(12):8172-8187. PubMed ID: 35019598
[TBL] [Abstract][Full Text] [Related]
14. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
Mohammed L; Ragab D; Gomaa H
Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
[TBL] [Abstract][Full Text] [Related]
15. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis.
Mahmoudi M; Sahraian MA; Shokrgozar MA; Laurent S
ACS Chem Neurosci; 2011 Mar; 2(3):118-40. PubMed ID: 22778862
[TBL] [Abstract][Full Text] [Related]
16. Functionalized Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as Platform for the Targeted Multimodal Tumor Therapy.
Janko C; Ratschker T; Nguyen K; Zschiesche L; Tietze R; Lyer S; Alexiou C
Front Oncol; 2019; 9():59. PubMed ID: 30815389
[TBL] [Abstract][Full Text] [Related]
17. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups.
Hong SC; Lee JH; Lee J; Kim HY; Park JY; Cho J; Lee J; Han DW
Int J Nanomedicine; 2011; 6():3219-31. PubMed ID: 22238510
[TBL] [Abstract][Full Text] [Related]
18. The selective toxicity of superparamagnetic iron oxide nanoparticles (SPIONs) on oral squamous cell carcinoma (OSCC) by targeting their mitochondria.
Afrasiabi M; Seydi E; Rahimi S; Tahmasebi G; Jahanbani J; Pourahmad J
J Biochem Mol Toxicol; 2021 Jun; 35(6):1-8. PubMed ID: 33704875
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
20. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
